Ultima Genomics
In Brief This Week: Meridian Bioscience, SQI Diagnostics, Applied DNA, Abbott, Danaher, More
News items for the week of Feb. 6, 2023.
AGBT: cfDNA Methylation Profiling Shows Promise as Blood Biomarker for Congestive Heart Failure
Presenting at AGBT, Hebrew University of Jerusalem researchers showed plasma cfDNA methylation signals can potentially become biomarkers for cardiac diseases.
NY Genome Center Team Harnesses Ultima Genomics Platform for High-Sensitivity ctDNA Sequencing
Premium
Taking advantage of the new platform's low sequencing cost, the researchers sequenced cell-free circulating DNA (ccfDNA) in plasma at high depth for sensitive cancer monitoring.
JP Morgan Healthcare Conference, Day 1: Guardant Health, Exact Sciences, Bruker, 10x Genomics, More
Highlights from the first day included Exact Sciences' profitability forecast, an update on QuidelOrtho's integration, and Guardant Health's "quantum leap forward" with its "smart" liquid biopsy platform.
Customers are feeling euphoric, but sequencing firms face a number of headaches including competitive pressure and global macroeconomic concerns.